drugset / Trial / NCT01543139
Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This proposed research is aimed to investigate the efficacy and safety of combined cytidine- and creatine-containing drug and dietary supplement in treating bipolar depression and to evaluate changes in relevant brain biochemical metabolism using magnetic resonance spectroscopy.
Timeline
- Start
- 2015-12-01
- Primary completion
- 2017-04-30
- Completion
- 2017-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Creatine | Other / unclassified | 5 g | — |
| Comparator | Cytidine | Small molecule | 2 g | — |
| Comparator | Valproate | Small molecule | 300 mg | — |